Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Allergy|March 6, 2025
Non-Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First-In-Class IgE Antibody Recognising Folate Receptor AlphaChara Stavraka, Jitesh Chauhan, Silvia Crescioli, et al.
Nature Communications|July 25, 2023
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trialJames Spicer, Bristi Basu, Ana Montes, et al.
Plos One|May 2, 2018
Exome array analysis of adverse reactions to fluoropyrimidine-based therapy for gastrointestinal cancerMatthew Traylor, Jemma L Walker, Adele A Corrigan, et al.
Future Oncology (London, England)|May 7, 2020
NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121)Mairéad Geraldine McNamara, Lipika Goyal, Mark Doherty, et al.
British Journal of Cancer|November 19, 2022
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomesHeather J Bax, Jitesh Chauhan, Chara Stavraka, et al.
The Lancet. Gastroenterology & Hepatology|June 27, 2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trialTim Meyer, Richard Fox, Yuk Ting Ma, et al.
British Journal of Cancer|June 22, 2018
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trialAlison C Backen, Andre Lopes, Harpreet Wasan, et al.
The Lancet. Oncology|July 17, 2015
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trialJuan W Valle, Harpreet Wasan, Andre Lopes, et al.
Clinical Colorectal Cancer|October 26, 2021
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic FactorsChara Stavraka, Athanasios Pouptsis, Alicja Synowiec, et al.
Cancer Research|January 19, 2017
Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 SignalingDebra H Josephs, Heather J Bax, Tihomir Dodev, et al.
Pageof 10